Myasthenia Gravis: IVIG and Soliris Infusion Options
MG causes muscle weakness that can affect breathing and swallowing in severe cases. Two different infusion therapies offer real options depending on your specific diagnosis.
What is myasthenia gravis?
Myasthenia gravis (MG) is an autoimmune condition in which antibodies block or damage the connection between nerves and muscles, causing weakness that typically worsens with activity and improves with rest. It often first affects the eyes (drooping eyelids, double vision) before potentially involving muscles used for swallowing, speaking, and breathing.
A subset of patients have a form called generalized myasthenia gravis (gMG), where weakness extends beyond the eye muscles and can significantly affect daily function.
How infusion therapy helps
IVIG is a well-established treatment for MG, particularly useful during flares (myasthenic crisis) or when standard oral medications aren't enough, working by modulating the immune response attacking the nerve-muscle connection.
For generalized MG specifically, Soliris (eculizumab) offers another option, targeting a different part of the immune system (the complement pathway) implicated in the nerve-muscle damage, typically for patients who test positive for a specific antibody (AChR-positive).
Managing myasthenia gravis?
Our physician-led team coordinates IVIG or Soliris therapy with your neurologist based on your specific diagnosis.
Call (551) 336-5580This article is for general educational purposes and is not a substitute for medical advice. Treatment decisions should always be made with your physician based on your individual diagnosis and health history.